Gene-ius at stake: who really cracked CRISPR in plants and animals?
3 June 2025
Many of our readers will have first heard of CRISPR-Cas9 a number of years ago.
Read on
Suzy Madar
Regulatory spotlight on telehealth
3 June 2025
Health Minister Mark Butler has requested that the Therapeutic Goods Administration consider ‘options to improve standards of telehealth’ in online prescribing.
Read on
One year on: the Treaty, WIPO, Traditional Knowledge, and patents
15 May 2025
Imagine an organisation obtaining patent protection over a formulation derived from Kakadu plum, while the First Nations community whose Knowledge guided the discovery receives neither recognition nor benefit.
Read on
A new prescription for prescribing? AHPRA’s prescription framework gets a health check
3 April 2025
The Australian Health Practitioner Regulation Agency (AHPRA) is currently undertaking a comprehensive review of the second edition of the Prescribing Competencies Framework — Embedding quality use of medicines into practice (the Framework) that outlines the competencies and expectations for safe and effective prescribing.
Read on
Substance over form(ulations)? An update on patent term extensions
18 February 2025
Two recent Federal Court decisions illustrate that term extensions are available for a broad range of patents, including formulation patents.
Read on
It’s alive! Safe and responsible AI in therapeutic goods
3 December 2024
Imagine a future where medical devices, powered by artificial intelligence, are seamlessly integrated into our lives.
Read on
The patentability of software in the US
12 November 2024
We are lucky to share with you insights from our New York patent experts Charles Wizenfeld, Michael S.
Read on
Proposed modifications to the regulation of gene technology in Australia
4 November 2024
The Department of Health and Aged Care is proposing the first major amendments to the Gene Technology Act 2000 (Cth) (the Act) since its commencement.
Read on
The mRNA patent wars: lessons for businesses & organisations who rely on patent rights
28 October 2024
Two weeks ago, GlaxoSmithKline (GSK) filed proceedings against the makers of the COVID-19 SPIKEVAX® vaccine, Moderna, Inc in the US Federal District Court in Delaware alleging that Moderna has infringed its patents relating to messenger RNA (mRNA) technology.
Read on
IPO 2018: Insights from the USPTO, EPO and the bench (when digital natives meet digital immigrants)
28 September 2018
The Intellectual Property Owners Association’s 46th Annual Meeting took place in Chicago from 23 to 25 September 2018.
Read on
Load More Posts